Data were analyzed in three ways: acute administration (injection 1), repeated administration (injections 1, 3, and 8), and post-treatment effects (days 1 and 3 post-treatment)
reported weight loss of 8.8% with liraglutide and 12.9% with semaglutide in a total of 207 patients, 7.7% of whom had T2D [6, 11, 12]
infantis FB3-14 in high-fat diet mouse models and found that an 8-week intervention significantly suppressed body weight gain, improved serum lipid parameters, and increased the abundance of beneficial gut bacteria including Akkermansia muciniphila
Thank you to our sponsors AG1 (Athletic Greens): Thesis: InsideTracker: ROKA: Supplements from Momentous For the full show notes, visit hubermanlab.com Timestamps (00:00:00) Nicotine (00:02:47) Momentous Supplements (00:03:41) Tool: Brief Daily Meditation & Focus (00:05:59) The Arrow Model of Focus, Alpha GPC & Garlic Supplements (00:10:43) Thesis, InsideTracker, ROKA (00:14:35) Nicotine Effects vs